Copyright
©The Author(s) 2020.
World J Clin Oncol. Feb 24, 2020; 11(2): 53-73
Published online Feb 24, 2020. doi: 10.5306/wjco.v11.i2.53
Published online Feb 24, 2020. doi: 10.5306/wjco.v11.i2.53
Score | PET/CT scan result | At iPET | At end-of-treatment |
1 | No uptake | CMR | CMR |
2 | Uptake ≤ mediastinum | CMR | CMR |
3 | Liver ≥ Uptake > mediastinum | Inadequate response | Good prognosis |
4 | Uptake moderately higher than liver | PMR | Treatment failure |
5 | Uptake markedly higher than liver and/or new lesions | PMR | Treatment failure |
X | New areas of uptake unlikely to be related to lymphoma |
- Citation: Aykan NF, Özatlı T. Objective response rate assessment in oncology: Current situation and future expectations. World J Clin Oncol 2020; 11(2): 53-73
- URL: https://www.wjgnet.com/2218-4333/full/v11/i2/53.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i2.53